Burning Rock Biotech (BNR) EBIT Margin (2019 - 2026)
Burning Rock Biotech (BNR) posted quarterly EBIT Margin of 17.45% for Q1 2026, down 604.0% year-over-year from 3.46% in Q1 2025, and down 83.17% quarter-over-quarter from 9.53% in Q4 2025.
Burning Rock Biotech (BNR) EBIT Margin (2019 - 2026) Analysis & Trends
Burning Rock Biotech's EBIT Margin history runs 8 years deep, the most recent figure standing at 17.45% for Q1 2026.
- In Q1 2026, EBIT Margin fell 604.0% year-over-year to 17.45%; the TTM figure through Mar 2026 stood at 11.41% (up 3560.0% YoY), while the FY2025 annual figure was 10.02%, up 5930.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 17.45%, down from 9.53% in the prior quarter.
- The five-year high for EBIT Margin was 7.74% in Q2 2025, with the low at 202.9% in Q2 2022.
- The 5-year median for EBIT Margin is 92.79% (2023), against an average of 90.57%.
- The sharpest annual moves came in 2022 and 2024: EBIT Margin slumped 4417 bps in 2022, then surged 11016 bps in 2024.
- Burning Rock Biotech's EBIT Margin stood at 152.88% in 2022, then increased by 10 bps to 137.37% in 2023, then jumped by 53 bps to 65.01% in 2024, then jumped by 85 bps to 9.53% in 2025, then slumped by 83 bps to 17.45% in 2026.
- Business Quant data shows BNR's EBIT Margin at 17.45% in Q1 2026, 9.53% in Q4 2025, and 12.26% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.99% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.98% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.58% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -13.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.97% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | Burning Rock Biotech | 781.17 Mn | 711.04 Mn | 11.31 Mn | -17.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.45% |
| Dec 31, 2025 | -9.53% |
| Sep 30, 2025 | -12.26% |
| Jun 30, 2025 | -7.74% |
| Mar 31, 2025 | -11.41% |
| Dec 31, 2024 | -65.01% |
| Sep 30, 2024 | -30.00% |
| Jun 30, 2024 | -82.06% |
| Mar 31, 2024 | -100.16% |
| Dec 31, 2023 | -137.37% |
| Sep 30, 2023 | -140.16% |
| Jun 30, 2023 | -92.79% |
| Mar 31, 2023 | -132.24% |
| Dec 31, 2022 | -152.88% |
| Sep 30, 2022 | -151.74% |
| Jun 30, 2022 | -202.90% |
| Mar 31, 2022 | -193.95% |
| Dec 31, 2021 | -171.11% |
| Sep 30, 2021 | -135.09% |
| Jun 30, 2021 | -158.73% |